Mortalidad en pacientes con CP según grupo de riesgo
17
Platinum Priority – Prostate Cancer
Editorial by UrsE. Studer and Peter C. Albertsen on pp. 97–99 of this issue
Long-term Outcomes Among Noncuratively Treated Men
According to Prostate Cancer Risk Category in a Nationwide,
Population-based Study
Jennifer R. Rider
a
,
*
, Fredrik Sandin
b
, Ove Andre´n
c
, Peter Wiklund
d
,
Jonas Hugosson
e
, Pa¨r Stattin
f
a
Channing Laboratory, Department of Medicine,Brigham and Women’sHospital and Harvard Medical School; and Department of Epidemiology,Harvard
School ofPublicHealth,Boston,MA,USA;
b
Regional Cancer Center,Uppsala,Sweden;
c
Department ofUrology,O¨rebroUniversity Hospital,O¨rebro,Sweden;
d
Department ofMolecular MedicineandSurgery,DivisionofUrology,KarolinskaInstitute,Stockholm,Sweden;
e
Department ofUrology,InstituteofClinical
Sciences,Sahlgrenska Academy at University of Go¨teborg,Go¨teborg,Sweden;
f
Department of Surgical and PerioperativeSciences,Urology,and Andrology,
Umea˚University,Umea˚,Sweden; and Department of Surgery,Urology Service,Memorial Sloan-KetteringCancer Center,New York,NY,USA
EUROPEAN UROLOGY 63 (2013) 88–96
available at
journal homepage:
Article info
Abstract
